Pentacel Kit
Product Images NDC 49281-511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pentacel (NDC 49281-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Pentacel 01)

Figure (Pentacel 01)
This document provides instructions about how to properly reconstitute and administer Pentacel vaccine, which includes the DTaP-1PV component and the lyophilized ActHIB vaccine component. The figures show the necessary steps, such as shaking the DTaP-1PV vial, inserting the syringe needle through the stopper of the ActHIB vial, withdrawing the entire liquid content, and swirling the vial gently. The vaccine should be used immediately after reconstitution and administered intramuscularly.*
FDA Label Image

Principal Display Panel (Kit Package)

Principal Display Panel (Kit Package)
This is a product description for a vaccine called DTaP-IPV/Hib, which is used for children between 6 weeks and 4 years of age to protect against diphtheria, tetanus, pertussis, inactivated poliovirus, and haemophilus B. The vaccine comes in 5 single-dose vials and is administered via intramuscular injection. The vaccine is manufactured by Sanofi Pasteur and contains a combination of different antigens, including diphtheria toxoid, tetanus toxoid, and various components of the pertussis bacterium, as well as inactivated poliovirus and haemophilus B. The vaccine must be stored at 2-8°C and should not be frozen. This text also contains lot number, expiration date, serial number and barcode information for tracking the vaccine.*
FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Principal Display Panel (0.5 mL Vial Label)
This is a description of a pharmaceutical product. The product is labeled as NDC 49281-561-01 with a volume of 0.5 mL. It contains the DTaP-IPV component which is part of the Pentacel vaccine. It is not meant to be used on its own but only to reconstitute ActHIB. The manufacturer is Sanofi Pasteur Limited with an address of 7420.*
FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Principal Display Panel (0.5 mL Vial Label)
This is a description of a Haemophilus b Conjugate Vaccine product with single dose for ages 6 weeks to 4 years. It is manufactured by Sanofi Pasteur SA and is a component of Pentacel®. The LOT NUMBER and EXPIRY DATE are also mentioned in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.